NEVRO CORP. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 1st, 2023 • Nevro Corp • Surgical & medical instruments & apparatus • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Greg Siller (“Executive”) and Nevro Corp. (the “Company”). This Agreement is effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
NEVRO CORP. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 1st, 2023 • Nevro Corp • Surgical & medical instruments & apparatus • California
This Amended and Restated Employment Agreement (the “Agreement”) is made and entered into by and between D. Keith Grossman (“Executive”) and Nevro Corp. (the “Company” and, together with Executive, the “Parties”), effective as of April 24, 2023 (the “Effective Date”).
SEPARATION AGREEMENTSeparation Agreement • August 1st, 2023 • Nevro Corp • Surgical & medical instruments & apparatus • California
This Separation Agreement (this “Agreement”) is entered into as of June 30, 2023 between Niamh Pellegrini (“Executive”) and Nevro Corp., a Delaware corporation (the “Company”), effective as of the eighth day following the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts:
AMENDMENT NO. 1 TO CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 1st, 2023 • Nevro Corp • Surgical & medical instruments & apparatus
This Amendment No. 1 (this “Amendment”) to the Change in Control Severance Agreement (the “Agreement”), dated as of April 19, 2023, by and between Rod MacLeod (“Executive”) and Nevro Corp. (the “Company”) is entered into effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
AMENDMENT NO. 1 TO CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 1st, 2023 • Nevro Corp • Surgical & medical instruments & apparatus
This Amendment No. 1 (this “Amendment”) to the Change in Control Severance Agreement (the “Agreement”), dated as of April 19, 2023, by and between Niamh Pellegrini (“Executive”) and Nevro Corp. (the “Company”) is entered into effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
AMENDMENT NO. 1 TO AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 1st, 2023 • Nevro Corp • Surgical & medical instruments & apparatus
This Amendment No. 1 (this “Amendment”) to the Amended and Restated Change in Control Severance Agreement (the “Agreement”), dated as of April 19, 2023, by and between Kashif Rashid (“Executive”) and Nevro Corp. (the “Company”) is entered into effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
